Prediction of hypersensitivity to antibiotics: what factors need to be considered?

References

• World Health Organization. International drug monitoring: the role of national centres. World Health Organ. Tech. Rep. Ser. 498, 1–25 (1972).
   PubMedGoogle Scholar
• Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 356(9237), 1255–1259 (2000).
   PubMed Web of Science ®Google Scholar
• Rawlins MD, Thompson JW. Pathogenesis of Adverse Drug Reactions. Oxford University Press, Oxford, UK (1977).
   Google Scholar
• Johansson SG, Bieber T, Dahl R et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organisation. J. Allergy Clin. Immunol. 113(5), 832–836 (2004).
   PubMed Web of Science ®Google Scholar
• Gell PGH, Coombs RRA. Clinical aspects of immunology. Blackwell, Oxford, UK (1963).
   Google Scholar
• Doña I, Blanca-López N, Torres MJ et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J. Investig. Allergol. Clin. Immunol. 22(5), 363–371 (2012).
   PubMed Web of Science ®Google Scholar
• Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr. Opin. Allergy Clin. Immunol. 5(4), 309–316 (2005).
   PubMed Web of Science ®Google Scholar
• Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br. J. Clin. Pharmacol. 71(5), 684–700 (2011).
   PubMed Web of Science ®Google Scholar
• Blanca M. Allergic reactions to penicillins. A changing world? Allergy 50(10), 777–782 (1995).
   PubMedGoogle Scholar
• Torres MJ, Ariza A, Mayorga C et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J. Allergy Clin. Immunol. 125(2), 502–505 (2010).
   PubMed Web of Science ®Google Scholar
• Blanca-Lopez N, Andreu I, Torres MJ. Hypersensitivity reactions to quinolones. Curr. Opin. Allergy Clin. Immunol. 11(4), 285–291 (2011).
   PubMedGoogle Scholar
• Clavenna A, Bonati M. Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Arch. Dis. Child. 94(9), 724–728 (2009).
   PubMed Web of Science ®Google Scholar
• Rebelo Gomes E, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin. Exp. Allergy 38(1), 191–198 (2008).
   PubMed Web of Science ®Google Scholar
• Rubio M, Bousquet PJ, Gomes E, Romano A, Demoly P. Results of drug hypersensitivity evaluations in a large group of children and adults. Clin. Exp. Allergy 42(1), 123–130 (2012).
   PubMed Web of Science ®Google Scholar
• Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 118(2), 555–562 (2006).
   PubMed Web of Science ®Google Scholar
• Ponvert C, Perrin Y, Bados-Albiero A et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr. Allergy Immunol. 22(4), 411–418 (2011).
   PubMed Web of Science ®Google Scholar
• Blanca-Lopez N, Zapatero L, Alonso E et al. Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy 64(2), 229–233 (2009).
   PubMedGoogle Scholar
• Tortajada Girbes M, Ferrer Franco A, Gracia Antequera M, Clement Paredes A, Garcia Muñoz E, Tallon Guerola M. Hypersensitivity to clavulanic acid in children. Allergol. Immunopathol. (Madr). 36(5), 308–310 (2008).
   PubMedGoogle Scholar
• Hasdenteufel F, Luyasu S, Hougardy N et al. Structure-activity relationships and drug allergy. Curr. Clin. Pharmacol. 7(1), 15–27 (2012).
   PubMedGoogle Scholar
• Landsteiner K, Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J. Exp. Med. 61(5), 643–656 (1935).
   PubMedGoogle Scholar
• Meng X, Jenkins RE, Berry NG et al. Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients. J. Pharmacol. Exp. Ther. 338, 841–849 (2011).
   PubMedGoogle Scholar
• Jenkins RE, Meng X, Elliott VL, Kitteringham NR, Pirmohamed M, Park BK. Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo. Proteomics Clin. Appl. 3, 720–729 (2009).
   PubMed Web of Science ®Google Scholar
• Whitaker P, Meng X, Lavergne SN et al. Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis. J. Immunol. 187, 200–211 (2011).
   PubMed Web of Science ®Google Scholar
• Carey MA, van Pelt FN. Immunochemical detection of flucloxacillin adduct formation in livers of treated rats. Toxicology 216, 41–48 (2005).
   PubMed Web of Science ®Google Scholar
• Park BK, Laverty H, Srivastava A, Antoine DJ, Naisbitt D, Williams DP. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Chem. Biol. Interact. 192, 30–36 (2011).
   PubMed Web of Science ®Google Scholar
• Lin D, Saleh S, Liebler DC. Reversibility of covalent electrophile-protein adducts and chemical toxicity. Chem. Res. Toxicol. 21, 2361–2369 (2008).
   PubMedGoogle Scholar
• Saha S, Harrison SH, Chen JY. Dissecting the human plasma proteome and inflammatory response biomarkers. Proteomics 9, 470–484 (2009).
   PubMedGoogle Scholar
• Enoch SJ, Roberts DW, Cronin MT. Mechanistic category formation for the prediction of respiratory sensitization. Chem. Res. Toxicol. 23, 1547–1555 (2010).
   PubMed Web of Science ®Google Scholar
• Uetrecht J. Immune-mediated adverse drug reactions. Chem. Res. Toxicol. 22, 24–34 (2009).
   PubMed Web of Science ®Google Scholar
• Andreu I, Mayorga C, Miranda MA. Metabolomics in drug intolerance. Curr. Drug Metab. 10, 947–955 (2009).
   PubMed Web of Science ®Google Scholar
• Roychowdhury S, Vyas PM, Reilly TP, Gaspari AA, Svensson CK. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J. Pharmacol. Exp. Ther. 314, 43–52 (2005).
   PubMed Web of Science ®Google Scholar
• Lavergne SN, Whitaker P, Peckham D, Conway S, Park BK,Naisbitt DJ. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis. Chem. Res. Toxicol. 23, 1009–1011 (2010).
   PubMedGoogle Scholar
• Roller SG, Dieckhaus CM, Santos WL, Sofia RD, Macdonald TL. Interaction between human serum albumin and the felbamate metabolites 4-Hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-phenylpropenal. Chem. Res. Toxicol. 15, 815–824 (2002).
   PubMed Web of Science ®Google Scholar
• Damsten MC, Commandeur JN, Fidder A et al. Liquid chromatography/tandem mass spectrometry detection of covalent binding of acetaminophen to human serum albumin. Drug Metab. Dispos. 35, 1408–1417 (2007).
   PubMedGoogle Scholar
• Andreu I, Mayorga C, Miranda MA. Generation of reactive intermediates in photoallergic dermatitis. Curr. Opin. Allergy Clin. Immunol. 10, 303–308 (2010).
   PubMedGoogle Scholar
• Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr. Opin. Allergy Clin. Immunol. 2(4), 301–305 (2002).
   PubMed Web of Science ®Google Scholar
• Blanca M, Romano A, Torres MJ et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 64(2), 183–193 (2009).
   PubMed Web of Science ®Google Scholar
• Brockow K, Garvey LH, Aberer W et al. Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 68(6), 702–712 (2013).
   PubMed Web of Science ®Google Scholar
• Smith H, Dewdney JM, Wheeler AW. A comparison of the amounts and the antigenicity of polymeric materials formed in aqueous solution by some beta-lactam antibiotics. Immunology 21(3), 527–533 (1971).
   PubMedGoogle Scholar
• Mazzeo F, Capuano A, Avolio A, Filippelli A, Rossi F. Hospital-based intensive monitoring of antibiotic-induced adverse events in a university hospital. Pharmacol. Res. 51(3), 269–274 (2005).
   PubMedGoogle Scholar
• Demoly P, Bousquet J. Epidemiology of drug allergy. Curr. Opin. Allergy Clin. Immunol. 1(4), 305–310 (2001).
   PubMed Web of Science ®Google Scholar
• Pawelec G, Barnett Y, Forsey R et al. T cells and aging, January 2002 update. Front. Biosci. 7, 1056–1183 (2002).
   PubMed Web of Science ®Google Scholar
• Chng HH, Leong KP, Cheng YK et al. Elderly inpatients have drug allergy manifestations and outcome similar to the non-elderly but serious reactions are less common: results of a 9-year prospective study. Allergy 63( Suppl. 88), 379 (2008).
   Google Scholar
• Gamboa PM. The epidemiology of drug allergy-related consultations in Spanish Allergology services: Alergologica-2005. J. Investig. Allergol. Clin. Immunol. 19( Suppl. 2), 45–50 (2009).
   PubMedGoogle Scholar
• Thong BY, Tang CY, Chng HH. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann. Allergy Asthma Immunol. 90(3), 342–347 (2003).
   PubMed Web of Science ®Google Scholar
• Wisniewski J, Agrawal R, Woodfolk JA. Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts. Clin. Exp. Allergy 43(2), 164–176 (2013).
   PubMed Web of Science ®Google Scholar
• Haddi E, Charpin D, Tafforeau M et al. Atopy and systemic reactions to drugs. Allergy 45(3), 236–239 (1990).
   Google Scholar
• McFadden JP, Dearman RJ, White JM, Basketter DA, Kimber I. The Hapten-Atopy hypothesis II: the 'cutaneous hapten paradox'. Clin. Exp. Allergy 41(3), 327–337 (2011).
   PubMed Web of Science ®Google Scholar
• Kurt E, Demir AU, Cadirci O, Yildirim H, Pinar Eser T. Immediate-type drug hypersensitivity and associated factors in a general population. Allergol. Immunopathol. (Madr) 39(1), 27–31 (2011).
   PubMedGoogle Scholar
• Cornejo-Garcia JA, Gueant-Rodriguez RM, Torres MJ et al. Biological and genetic determinants of atopy are predictors of immediate-type allergy to betalactams, in Spain. Allergy 67(9), 1181–1185 (2012).
   PubMedGoogle Scholar
• Sanchez-Borges M, Acevedo N, Caraballo L, Capriles-Hulett A, Caballero-Fonseca F. Increased total and mite-specific immunoglobulin E in patients with aspirin-induced urticaria and angioedema. J. Investig. Allergol. Clin. Immunol. 20(2), 139–145 (2010).
   PubMed Web of Science ®Google Scholar
• Dona I, Blanca-Lopez N, Cornejo-Garcia JA et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin. Exp. Allergy 41(1), 86–95 (2011).
   PubMed Web of Science ®Google Scholar
• Hubiche T, Milpied B, Cazeau C, Taieb A, Leaute-Labreze C. Association of immunologically confirmed delayed drug reaction and human herpesvirus 6 viremia in a pediatric case of drug-induced hypersensitivity syndrome. Dermatology 222, 140–141 (2011).
   PubMedGoogle Scholar
• Ozcan D, Seckin D, Bilezikci B, Arslan H. The role of human herpesvirus-6, Epstein-Barr virus and cytomegalovirus infections in the etiopathogenesis of different types of cutaneous drug reactions. Int. J. Dermatol. 49, 1250–1254 (2010).
   PubMedGoogle Scholar
• Phillips E, Mallal S. Drug hypersensitivity in HIV. Curr. Opin. Allergy Clin. Immunol. 7(4), 324–330 (2007).
   PubMed Web of Science ®Google Scholar
• Lang DM, Alpern MB, Visintainer PF, Smith ST. Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann. Intern. Med. 115(4), 270–276 (1991).
   PubMed Web of Science ®Google Scholar
• Petri M, Allbritton J. Antibiotic allergy in systemic lupus erythematosus: a case-control study. J. Rheumatol. 19(2), 265–269 (1992).
   PubMed Web of Science ®Google Scholar
• Aihara Y, Ito SI, Kobayashi Y, Yamakawa Y, Aihara M, Yokota S. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br. J. Dermatol. 149(1), 165–169 (2003).
   PubMedGoogle Scholar
• Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch. Dermatol. 140(2), 183–188 (2004).
   PubMedGoogle Scholar
• Chung WH, Hung SI, Hong HS et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428(6982), 486 (2004).
   PubMedGoogle Scholar
• Man CB, Kwan P, Baum L et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 48(5), 1015–1018 (2007).
   PubMed Web of Science ®Google Scholar
• Kaniwa N, Saito Y, Aihara M et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9(11), 1617–1622 (2008).
   PubMed Web of Science ®Google Scholar
• Mallal S, Phillips E, Carosi G et al. HLA-B*5701 screening for hypersensitivity to abacavir. N. Engl. J. Med. 358, 568–579 (2008).
   PubMed Web of Science ®Google Scholar
• Saag M, Balu R, Phillips E et al. High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clin. Infect. Dis. 46, 1111–1118 (2008).
   PubMed Web of Science ®Google Scholar
• Qiao HL, Yang J, Zhang YW. Relationships between specific serum IgE, cytokines and polymorphisms in the IL-4, IL-4Ralpha in patients with penicillins allergy. Allergy 60(8), 1053–1059 (2005).
   PubMedGoogle Scholar
• Gueant-Rodriguez RM, Romano A, Beri-Dexheimer M, Viola M, Gaeta F, Gueant JL. Gene-gene interactions of IL13 and IL4RA variants in immediate allergic reactions to betalactam antibiotics. Pharmacogenet. Genomics 16(10), 713–719 (2006).
   PubMedGoogle Scholar
• Huang CZ, Yang J, Qiao HL, Jia LJ. Polymorphisms and haplotype analysis of IL-4Ralpha Q576R and I75V in patients with penicillin allergy. Eur. J. Clin. Pharmacol. 65(9), 895–902 (2009).
   PubMedGoogle Scholar
• Guglielmi L, Fontaine C, Gougat C et al. IL-10 promoter and IL4-Ralpha gene SNPs are associated with immediate beta-lactam allergy in atopic women. Allergy 61(8), 921–927 (2006).
   PubMedGoogle Scholar
• Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 329(7456), 15–19 (2004).
   PubMed Web of Science ®Google Scholar
• Adkinson NF Jr, Essavan D, Gruchalla R et al. Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J. Allergy Clin Immunol. 109(3), 461–478 (2002).
   Web of Science ®Google Scholar
• Britschgi M, Von Greyerz S, Burkhart C, Pichler WJ. Molecular aspects of drug recognition by specific T cells. Curr. Drug Targets 2003. 4(1), 1–11 (2003).
   PubMed Web of Science ®Google Scholar
• Park MA, Matesic D, Markus PJ, Li JT. Female sex as a risk factor for penicillin allergy. Ann. Allergy Asthma Immunol. 99(1), 54–58 (2007).
   PubMedGoogle Scholar
• Zurawski SM, Vega F Jr, Huyghe B, Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12(7), 2663–2670 (1993).
   PubMedGoogle Scholar
• Romano A, De Santis A, Romito A et al. Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. Ann. Allergy Asthma Immunol. 80(5), 433–437 (1998).
   PubMedGoogle Scholar
• Sachs B, Riegel S, Seebeck J et al. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf. 29(11), 1087–1100 (2006).
   PubMedGoogle Scholar
• Aranda A, Mayorga C, Ariza A et al. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 66(2), 247–254 (2011).
   PubMedGoogle Scholar
• Seitz CS, Brocker EB, Trautmann A. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin. Exp. Allergy 39(11), 1738–1745 (2009).
   PubMedGoogle Scholar
• Johannes CB, Ziyadeh N, Seeger JD et al. Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation. Drug Saf. 30(8), 705–713 (2007).
   PubMedGoogle Scholar
• Blanca-Lopez N, Ariza A, Doña I et al. Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clin. Exp. Allergy 43(5), 560–567 (2013).
   PubMedGoogle Scholar
• Sullivan TJ, Remedio C, Ong MD, Gilliam LK. Studies of the multiple drug allergy syndrome. J. Allergy Clin. Immunol. 83, 270 (1989).
   Google Scholar